Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Stephanie DeArmey
Observed names:
STEPHANIE M. DEARMEY,
Stephanie Dearmey,
Stephanie L. DeArmey,
Stephanie M. DeArmey,
Stephanie M. Dearmey
Institutions:
Duke University,
Duke Medical Center
Observed institutions:
Duke University,
LMU Klinikum,
Duke Medical Center,
Duke University Health System,
Centre for the Observation and Modelling of Earthquakes, Volcanoes and Tectonics,
Ludwig-Maximilians-Universität München
show all 6
OpenAlex ID:
A5032261871
Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants
2009
·
Priya S. Kishnani
, Paula C. Goldenberg
, et al.
·
Molecular Genetics and Metabolism
·
414
Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial
2021
·
Jordi Diaz-Manera
, Priya S Kishnani
, et al.
·
The Lancet Neurology
·
215
PDF
The emerging phenotype of long-term survivors with infantile Pompe disease
2012
·
Sean N. Prater
, Suhrad G. Banugaria
, et al.
·
Genetics in Medicine
·
206
Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double-blind, parallel-group, phase 3 trial
2021
·
Benedikt Schoser
, Mark Roberts
, et al.
·
The Lancet Neurology
·
148
Algorithm for the Early Diagnosis and Treatment of Patients with Cross Reactive Immunologic Material-Negative Classic Infantile Pompe Disease: A Step towards Improving the Efficacy of ERT
2013
·
Suhrad G. Banugaria
, Sean N. Prater
, et al.
·
PLoS ONE
·
120
Efficacy and Safety of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease After 97 Weeks: A Phase 3 Randomized Clinical Trial
2023
·
Priya S. Kishnani
, Jordi Diaz-Manera
, et al.
·
JAMA Neurology
·
70
PDF
Higher dosing of alglucosidase alfa improves outcomes in children with Pompe disease: a clinical study and review of the literature
2020
·
Aleena A. Khan
, Laura E. Case
, et al.
·
Genetics in Medicine
·
66
Cardiac arrhythmias following anesthesia induction in infantile‐onset Pompe disease: a case series
2007
·
LUKE Y.‐J. WANG
, ALLISON K. ROSS
, et al.
·
Pediatric Anesthesia
·
65
PDF
Case series: Odontohypophosphatasia or missed diagnosis of childhood/adult-onset hypophosphatasia? – Call for a long-term follow-up of premature loss of primary teeth
2016
·
Mari Mori
, Stephanie L. DeArmey
, et al.
·
Bone Reports
·
62
PDF
Safety and efficacy of alternative alglucosidase alfa regimens in Pompe disease
2014
·
Laura E. Case
, Carl Bjartmar
, et al.
·
Neuromuscular Disorders
·
62
PDF
The clinical and electrodiagnostic characteristics of Pompe disease with post-enzyme replacement therapy findings
2011
·
Lisa D. Hobson-Webb
, Stephanie DeArmey
, et al.
·
Clinical Neurophysiology
·
62
Phase I study of liver depot gene therapy in late-onset Pompe disease
2023
·
Edward C. Smith
, Sam Hopkins
, et al.
·
Molecular Therapy
·
48
PDF
An individually, modified approach to desensitize infants and young children with Pompe disease, and significant reactions to alglucosidase alfa infusions
2011
·
Areeg H. El-Gharbawy
, Joanne Mackey
, et al.
·
Molecular Genetics and Metabolism
·
42
Use of cardiac magnetic resonance imaging to evaluate cardiac structure, function and fibrosis in children with infantile Pompe disease on enzyme replacement therapy
2010
·
Piers C.A. Barker
, Sara K. Pasquali
, et al.
·
Molecular Genetics and Metabolism
·
37
Improvement with ongoing Enzyme Replacement Therapy in advanced late-onset Pompe disease: A case study
2008
·
Laura E. Case
, Dwight D. Koeberl
, et al.
·
Molecular Genetics and Metabolism
·
36
104-week efficacy and safety of cipaglucosidase alfa plus miglustat in adults with late-onset Pompe disease: a phase III open-label extension study (ATB200-07)
2024
·
Benedikt Schoser
, Priya S. Kishnani
, et al.
·
Journal of Neurology
·
35
PDF
Polysomnographic findings in infantile Pompe disease
2013
·
Sujay Kansagra
, Stephanie Austin
, et al.
·
American Journal of Medical Genetics Part A
·
35
Fractures in children with Pompe disease: a potentiallong-term complication
2007
·
Laura E. Case
, Rabi Hanna
, et al.
·
Pediatric Radiology
·
34
Ocular and Histologic Findings in a Series of Children With Infantile Pompe Disease Treated With Enzyme Replacement Therapy
2014
·
S. Grace Prakalapakorn
, Alan D. Proia
, et al.
·
Journal of Pediatric Ophthalmology & Strabismus
·
33
Sensitivity of whole exome sequencing in detecting infantile- and late-onset Pompe disease
2017
·
Mari Mori
, Gloria Haskell
, et al.
·
Molecular Genetics and Metabolism
·
26
PDF
Enzyme replacement therapy with alglucosidase alfa in Pompe disease: Clinical experience with rate escalation
2017
·
Ankit K. Desai
, Crista K. Walters
, et al.
·
Molecular Genetics and Metabolism
·
21
PDF
Longitudinal polysomnographic findings in infantile Pompe disease
2015
·
Sujay Kansagra
, Stephanie Austin
, et al.
·
American Journal of Medical Genetics Part A
·
20
Pulmonary outcome measures in long‐term survivors of infantile Pompe disease on enzyme replacement therapy: A case series
2020
·
Mai K. ElMallah
, Ankit K. Desai
, et al.
·
Pediatric Pulmonology
·
16
Ectopic Ocular Surface Calcification in Patients With Hypophosphatasia Treated With Asfotase Alfa
2019
·
Sidney M. Gospe
, Cecilia Santiago-Turla
, et al.
·
Cornea
·
10
Corticobasal syndrome in a man with Gaucher disease type 1: Expansion of the understanding of the neurological spectrum
2018
·
Kunal C. Potnis
, Lauren B. Flueckinger
, et al.
·
Molecular Genetics and Metabolism Reports
·
8
PDF
Show more works
View as search
Works count:
50
Citation count:
1,926
H-index:
21
I10-index:
24
Year
Topic
Type